Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06073171Recruiting
Single-arm trial, sponsored by CHU Montpellier. Primary endpoint: Number of patients in whom a pathogenic or probably pathogenic variant has been identified by exome sequencing at 12 months. Started Jun 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06073171.